We did it!

Our campaign is now complete. 4011 supporters helped us raise £189,577.00

Visit the charity's profile
Closed 31/12/2019
Myeloma UK

Myeloma UK London Paris Ride 2019

Myeloma UK patients, carers and supporters cycling 500km from London to Paris in four days to raise funds for crucial myeloma research.
£189,577
raised
by 8045 supporters
Donations cannot currently be made to this page
Closed on 31/12/2019
RCN SC026116

Be a fundraiser

The campaign has now expired but it's not too late to support this charity.

Visit the charity's profile

Story

Research is critically important because myeloma is a complex cancer with no known cure. Its also relapsing and remitting which means many patients are in desperate need of that next treatment. At Myeloma UK, we work to accelerate the discovery and development of effective treatments, and ultimately, to find a cure for myeloma.

If you are unable to take part but want to support our riders and the work of Myeloma UK, you can use this page to make a donation and leave a message of support.

If you are taking part in our 2019 Ride, you can create your own Justgiving page from this page by clicking on the Fundraise for campaign button above.

To find out more about our ride and to watch videos from our 2018 ride visit: www.myeloma.org.uk/ride or follow #hopeonabike on social media.

Thank you for your support, together we will make myeloma history!

About the charity

Myeloma UK

Verified by JustGiving

RCN SC026116
Myeloma UK is the only organisation in the UK dealing exclusively with myeloma. We provide information and support to patients and their families and help myeloma patients live longer, with a better quality of life by accelerating the discovery, development of and access to new treatments.

Donation summary

Total raised
£189,576.60
+ £47.50 Gift Aid
Online donations
£177,873.66
Offline donations
£0.00
Direct donations
£190.00
Donations via fundraisers
£189,386.60

* Charities pay a small fee for our service. Find out how much it is and what we do for it.